Source comparison
CJC-1295 Tendon Healing Protocol Dosage Timing: Research Protocol Comparison
Dose per injection 200–300 mcg 300–400 mcg 100–200 mcg 200–300 mcg provides optimal balance between efficacy and side effect minimization across most research models Dosing frequency Twice weekly (every 3–4 days) Twice weekly Once weekly Twice-weekly maintains
This comparison does not assign a generated winner or score.
- Dose per injection
- 200–300 mcg
- 300–400 mcg
- 100–200 mcg
- 200–300 mcg provides optimal balance between efficacy and side effect minimization across most research models
- Dosing frequency
- Twice weekly (every 3–4 days)
- Twice weekly
- Once weekly
- Twice-weekly maintains stable plasma levels without receptor desensitization; once-weekly creates trough periods that reduce average IGF-1 exposure
- Injection timing
- Evening, 1–2 hours pre-sleep
- Evening, immediately pre-sleep
- Morning, fasted state
- Evening dosing aligns with circadian GH rhythm and removes cortisol interference present during morning administration
- Reconstitution volume
- 2 mL bacteriostatic water per 5 mg vial
- 1 mL bacteriostatic water per 5 mg vial
- 3 mL bacteriostatic water per 5 mg vial
- 2 mL provides accurate dosing precision (0.2 mL = 500 mcg) while minimizing injection volume discomfort
- Storage post-reconstitution
- Refrigerated 2–8°C, use within 28 days
- Refrigerated 2–8°C, use within 14 days
- Refrigerated 2–8°C, use within 60 days
- 28-day window reflects bacteriostatic water antimicrobial effectiveness; peptide degradation accelerates beyond this timeline even under refrigeration
- Synergistic peptide pairing
- CJC-1295 + GHRP-2 or Ipamorelin
- CJC-1295 alone
- CJC-1295 + Ipamorelin
- Pairing GHRH analog with GHRP prevents receptor desensitization and amplifies GH pulse amplitude by 3–5× versus single-peptide use